Streetbeat News

Analyst Ratings

KMX

RBC Capital analyst Steven Shemesh has maintained an 'Outperform' rating on CarMax (NYSE:KMX), but lowered the price target from $90 to $80.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 4:10 pm

ACN

RBC Capital analyst Daniel Perlin has reiterated his 'Outperform' rating on Accenture (NYSE:ACN) and maintained a price target of $340.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 4:08 pm

APRN

CAPR

EBET

NVOS

OPGN

VRAR

US stocks traded higher with the Nasdaq Composite gaining over 100 points. The PCE price index increased from 3.4% in July to 3.5% in August 2023. Novo Integrated Sciences shares shot up 58% after signing a $1bn Master Collateral Transfer Agreement with Blacksheep Trust. Blue Apron Holdings shares surged 133% after announcing an acquisition agreement with Wonder Group. OpGen shares gained 94% after requesting to withdraw its registration statement. The Glimpse Group shares dropped 42% after reporting FY23 financial results. Capricor Therapeutics shares were down 41% after announcing a $23m registered direct offering. EBET shares fell 26% after announcing a 1-for-30 reverse stock split.

Portfolio Pulse from Lisa Levin

September 29, 2023 | 4:05 pm

TSX:ONEX

RBC Capital analyst Geoffrey Kwan has maintained a 'Sector Perform' rating on Onex (TSX:ONEX) and lowered the price target from C$103 to C$102.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 4:03 pm

ERF

RBC Capital analyst Greg Pardy maintains an Outperform rating on Enerplus (NYSE:ERF) and raises the price target from $19 to $21.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 4:01 pm

DFS

Over the past 3 months, 15 analysts have published their opinion on Discover Financial Services (NYSE:DFS) stock. The company has an average price target of $113.6, a decrease of 4.09% from the previous average price target of $118.45. The majority of analysts are indifferent about the stock, with 2 analysts being bullish, 2 somewhat bullish, and 11 indifferent.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 4:00 pm

SWAV

ShockWave Medical (NASDAQ:SWAV) has received various analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, and 2 indifferent. The company's average 12-month price target is $289.4, a decrease of 5.58% from the previous average of $306.50.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 4:00 pm

ALLY

In the last quarter, Ally Financial (NYSE:ALLY) received a mix of bullish, somewhat bullish, and indifferent ratings from analysts. Over the past 3 months, 10 analysts have offered 12-month price targets for Ally Financial, with an average price target of $33.1, up by 3.83% from the previous average of $31.88.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 4:00 pm

AXP

In the last quarter, 12 analysts have provided ratings for American Express (NYSE:AXP), with an average 12-month price target of $177.58, a decrease of 3.34% from the previous average price target of $183.71. The ratings range from bullish to bearish, with the majority being indifferent.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 4:00 pm

SPGI

S&P Global's (NYSE:SPGI) short percent of float has fallen 13.73% since its last report, with 2.81 million shares sold short, which is 0.88% of all regular shares available for trading. It would take traders 2.52 days to cover their short positions on average. The company's short interest is less than its peer group average of 3.65%.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 4:00 pm